STAT+: Roche goes beyond licensing in deal with Chinese biotech
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Let’s get straight to the news. The need-to-know this morning Bristol Myers Squibb said Zenbexus, recently…
ImpactMinor 16/100
Why it mattersRule-based estimate: event keywords (+4), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published6 h ago (Thu, 08 Oct 2026 15:18:05 GMT)
RetrievedThu, 08 Oct 2026 16:00:17 GMT via rss
ClassifiedThu, 08 Oct 2026 16:00:35 GMT by heuristic
AuthorElaine Chen